STEPHANIE MOTT: Open Payments
NPI 1366633893 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 18 payments from 8 companies in 2025. Trend: 2023 $63 · 2024 $334 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $239 |
| Ardelyx, Inc. | 2 | $142 |
| UCB, Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Travere Therapeutics, Inc. | 1 | $25 |
| Calliditas Therapeutics US Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| OPKO Pharmaceuticals, LLC | 1 | $14 |
Products named: Fabhalta, XPHOZAH 30 MG, Bimzelx, JARDIANCE, IBSRELA, TARPEYO, JYNARQUE, RAYALDEE.
Industry payments across AL — which companies pay providers there.
